TmMSTN-01 / University of Pennsylvania, Gilead - LARVOL DELTA

CAR T Cells in Mesothelin Expressing Cancers (clinicaltrials.gov) - P1 | N=54 | Completed | Sponsor: University of Pennsylvania | Active, not recruiting ➔ Completed | Trial completion date: Mar 2025 ➔ Jul 2024 | Trial primary completion date: Mar 2025 ➔ Nov 2023

CAR T-Cell Therapy • Trial completion • Trial completion date • Trial primary completion date • Fallopian Tube Cancer • Lung Adenocarcinoma • Lung Cancer • Malignant Pleural Mesothelioma • Mesothelioma • Non Small Cell Lung Cancer • Oncology • Ovarian Cancer • Peritoneal Cancer • Solid Tumor • PD-L1

CAR T Cells in Mesothelin Expressing Cancers (clinicaltrials.gov) - P1 | N=65 | Active, not recruiting | Sponsor: University of Pennsylvania | Recruiting ➔ Active, not recruiting | N=27 ➔ 65

CAR T-Cell Therapy • Enrollment change • Enrollment closed • Fallopian Tube Cancer • Lung Adenocarcinoma • Lung Cancer • Malignant Pleural Mesothelioma • Mesothelioma • Non Small Cell Lung Cancer • Oncology • Ovarian Cancer • Peritoneal Cancer • Solid Tumor • PD-L1